Skip to main content

FDA Panel Backs RSV Vaccine for Infants, Some Toddlers

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

FRIDAY, June 9, 2023 -- A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve a respiratory syncytial virus (RSV) vaccine for infants and some toddlers.

The monoclonal antibody shot would protect against RSV in infants born during or entering their first RSV season, The New York Times reported. It could also be used for toddlers up to 24 months old who are particularly vulnerable to the virus.

The panel voted 21-0 in favor of using the vaccine, called Beyfortus, for infants and 19-2 in favor of use in toddlers, The Times said. Now, it is up to the FDA to decide whether to approve the vaccine, though it typically follows the recommendations of its panels. The agency has said it would continue to monitor the treatment for safety even after approval.

Drugmakers Sanofi and AstraZeneca gave more than 3,200 infants the antibody vaccine during studies of the vaccine. One of those studies showed that the vaccine's effectiveness against very severe RSV was 79 percent after six months.

A vaccine has recently been FDA-approved for older adults. Another -- which would be delivered to women in pregnancy to help shield newborns -- has been recommended by a different FDA panel, although there are concerns about a small increase in preterm births, The Times reported.

The vaccine for infants, if approved, could be available in the fall.

The New York Times Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted June 2023

Read this next

USDA, HHS Announce New Measures to Monitor, Prevent Bird Flu

FRIDAY, May 10, 2024 -- The U.S. Department of Agriculture and U.S. Department of Health & Human Services have jointly announced a myriad of initiatives aimed at preventing...

Personalized Tool Can Predict Infants at Increased Risk for RSV

THURSDAY, May 9, 2024 -- A personalized tool can predict infants at increased risk for severe respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) who would...

USDA Testing Beef for H5N1 Amid Current Outbreak in Dairy Cows

TUESDAY, April 30, 2024 -- On Monday, the U.S. Department of Agriculture announced that it is now testing ground beef for any presence of the H5N1 virus that continues to spread...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.